Universe Pharmaceuticals (UPC) Stock Price, News & Analysis

Company Overview

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

Key Stats

• Today's Range: $3.85 to $3.97
• 50-Day Range: N/A
• 52-Week Range: $2.51 to $2,592.00
• Volume: 26,211 shs
• Average Volume: 82,415 shs
• Market Capitalization: $158.80 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Universe Pharmaceuticals Stock Analysis - MarketRank™

Universe Pharmaceuticals scored higher than 27% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Universe Pharmaceuticals.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Universe Pharmaceuticals has a P/B Ratio of 0.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

95.81% of the float of Universe Pharmaceuticals has been sold short.

Short Interest Ratio / Days to Cover

Universe Pharmaceuticals has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Universe Pharmaceuticals has recently decreased by 59.37%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Universe Pharmaceuticals does not currently pay a dividend.

Dividend Growth

Universe Pharmaceuticals does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

95.81% of the float of Universe Pharmaceuticals has been sold short.

Short Interest Ratio / Days to Cover

Universe Pharmaceuticals has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Universe Pharmaceuticals has recently decreased by 59.37%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: N/A

News Sentiment

Universe Pharmaceuticals has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Universe Pharmaceuticals this week, compared to 0 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Universe Pharmaceuticals insiders have not sold or bought any company stock.

Percentage Held by Insiders

57.38% of the stock of Universe Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 0.18% of the stock of Universe Pharmaceuticals is held by institutions.

UPC Stock Analysis - Frequently Asked Questions

How have UPC shares performed this year?

Universe Pharmaceuticals' stock was trading at $4.67 at the beginning of the year. Since then, UPC shares have decreased by 15.0% and is now trading at $3.97.
View the best growth stocks for 2025 here.

When did Universe Pharmaceuticals IPO?

Universe Pharmaceuticals (UPC) raised $30 million in an IPO on Tuesday, March 23rd 2021. The company issued 5,000,000 shares at a price of $5.00-$7.00 per share. Univest Securities, LLC served as the underwriter for the IPO.

How do I buy shares of Universe Pharmaceuticals?

Shares of UPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 6/18/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED-DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:UPC
• CIK: 1809616
• Web: N/A
• Phone: 86-0796-8403309
• Fax: N/A
• Employees: 220
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.05
• Current Ratio: 2.54
• Quick Ratio: 2.46

Sales & Book Value

• Annual Sales: $23.02 million
• Price / Sales: 0.01
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $7,528.62 per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 40,000
• Free Float: 18,000
• Market Cap: $158.80 thousand
• Optionable: N/A
• Beta: 1.51